RhumbLine Advisers’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $706K | Buy |
410,495
+21,314
| +5% | +$36.7K | ﹤0.01% | 2437 |
|
|
2025
Q1 | $1.3M | Buy |
389,181
+3,411
| +0.9% | +$11.4K | ﹤0.01% | 2053 |
|
|
2024
Q4 | $2.85M | Buy |
385,770
+31,699
| +9% | +$235K | ﹤0.01% | 1708 |
|
|
2024
Q3 | $3.32M | Sell |
354,071
-14,729
| -4% | -$138K | ﹤0.01% | 1627 |
|
|
2024
Q2 | $2.96M | Sell |
368,800
-22,750
| -6% | -$182K | ﹤0.01% | 1678 |
|
|
2024
Q1 | $5.8M | Buy |
391,550
+23,094
| +6% | +$342K | 0.01% | 1336 |
|
|
2023
Q4 | $3M | Buy |
368,456
+16,289
| +5% | +$132K | ﹤0.01% | 1699 |
|
|
2023
Q3 | $1.6M | Sell |
352,167
-12,476
| -3% | -$56.8K | ﹤0.01% | 1967 |
|
|
2023
Q2 | $2.57M | Buy |
364,643
+124,752
| +52% | +$878K | ﹤0.01% | 1767 |
|
|
2023
Q1 | $1.47M | Buy |
239,891
+5,214
| +2% | +$31.9K | ﹤0.01% | 1968 |
|
|
2022
Q4 | $1.5M | Sell |
234,677
-2,452
| -1% | -$15.7K | ﹤0.01% | 1937 |
|
|
2022
Q3 | $2.27M | Buy |
237,129
+16,185
| +7% | +$155K | ﹤0.01% | 1683 |
|
|
2022
Q2 | $2.44M | Buy |
220,944
+97,707
| +79% | +$1.08M | ﹤0.01% | 1667 |
|
|
2022
Q1 | $2.05M | Sell |
123,237
-11,282
| -8% | -$188K | ﹤0.01% | 1806 |
|
|
2021
Q4 | $2.57M | Buy |
134,519
+4,603
| +4% | +$87.9K | ﹤0.01% | 1743 |
|
|
2021
Q3 | $3.2M | Sell |
129,916
-9,937
| -7% | -$245K | ﹤0.01% | 1625 |
|
|
2021
Q2 | $3.64M | Buy |
139,853
+2,703
| +2% | +$70.3K | ﹤0.01% | 1618 |
|
|
2021
Q1 | $4.34M | Sell |
137,150
-8,039
| -6% | -$255K | 0.01% | 1481 |
|
|
2020
Q4 | $6.74M | Sell |
145,189
-1,249
| -0.9% | -$58K | 0.01% | 1178 |
|
|
2020
Q3 | $4.82M | Sell |
146,438
-8,171
| -5% | -$269K | 0.01% | 1192 |
|
|
2020
Q2 | $4.24M | Sell |
154,609
-10,773
| -7% | -$296K | 0.01% | 1302 |
|
|
2020
Q1 | $4.95M | Buy |
165,382
+4,081
| +3% | +$122K | 0.01% | 1034 |
|
|
2019
Q4 | $4.47M | Buy |
161,301
+6,498
| +4% | +$180K | 0.01% | 1319 |
|
|
2019
Q3 | $2.82M | Sell |
154,803
-405
| -0.3% | -$7.37K | 0.01% | 1540 |
|
|
2019
Q2 | $3.81M | Buy |
155,208
+19,978
| +15% | +$490K | 0.01% | 1349 |
|
|
2019
Q1 | $1.29M | Sell |
135,230
-858
| -0.6% | -$8.16K | ﹤0.01% | 1915 |
|
|
2018
Q4 | $1.2M | Buy |
136,088
+64,879
| +91% | +$574K | ﹤0.01% | 1916 |
|
|
2018
Q3 | $801K | Sell |
71,209
-5,215
| -7% | -$58.7K | ﹤0.01% | 2094 |
|
|
2018
Q2 | $978K | Buy |
76,424
+5,465
| +8% | +$69.9K | ﹤0.01% | 2021 |
|
|
2018
Q1 | $1.2M | Buy |
70,959
+15,241
| +27% | +$258K | ﹤0.01% | 1859 |
|
|
2017
Q4 | $446K | Sell |
55,718
-8,347
| -13% | -$66.8K | ﹤0.01% | 2280 |
|
|
2017
Q3 | $497K | Buy |
64,065
+365
| +0.6% | +$2.83K | ﹤0.01% | 2309 |
|
|
2017
Q2 | $468K | Buy |
63,700
+5,030
| +9% | +$37K | ﹤0.01% | 2340 |
|
|
2017
Q1 | $437K | Buy |
58,670
+2,421
| +4% | +$18K | ﹤0.01% | 2308 |
|
|
2016
Q4 | $391K | Buy |
56,249
+7,033
| +14% | +$48.9K | ﹤0.01% | 2352 |
|
|
2016
Q3 | $405K | Sell |
49,216
-3,060
| -6% | -$25.2K | ﹤0.01% | 2315 |
|
|
2016
Q2 | $423K | Buy |
52,276
+7,276
| +16% | +$58.9K | ﹤0.01% | 2308 |
|
|
2016
Q1 | $229K | Buy |
45,000
+575
| +1% | +$2.93K | ﹤0.01% | 2671 |
|
|
2015
Q4 | $343K | Buy |
44,425
+3,440
| +8% | +$26.6K | ﹤0.01% | 2487 |
|
|
2015
Q3 | $236K | Buy |
40,985
+3,515
| +9% | +$20.2K | ﹤0.01% | 2693 |
|
|
2015
Q2 | $344K | Buy |
+37,470
| New | +$344K | ﹤0.01% | 2564 |
|